Shares of Moderna Inc. /zigman2/quotes/205619834/composite MRNA +6.06% shed 2.94% to $301.49 Thursday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP +1.65% rising 0.83% to 15,381.32 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.35% rising 1.82% to 34,639.79. This was the stock's third consecutive day of losses. Moderna Inc. closed $196.00 short of its 52-week high ($497.49), which the company achieved on August 10th.
The stock underperformed when compared to some of its competitors Thursday, as AbbVie Inc. /zigman2/quotes/202428675/composite ABBV +0.33% rose 0.83% to $116.87, Amgen Inc. /zigman2/quotes/209157011/composite AMGN +0.60% rose 0.18% to $201.17, and AstraZeneca PLC ADR /zigman2/quotes/200304487/composite AZN -0.97% fell 0.16% to $54.79. Trading volume (15.3 M) eclipsed its 50-day average volume of 13.2 M.